Luis Vitetta

prince of wales clinical school

H指数:50

被引数:7,349

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Associations Between Microbial Depletion and Autonomic Dysregulation in Binge-Eating Disorder

微生物耗竭与暴食症自主神经调节障碍之间的关联

International Journal of Eating Disorders

IF4.3

2026-05-310

OAAI

The Gut-Lung Axis, Epigenetics and Respiratory Disease

肠道-肺部轴、表观遗传学与呼吸系统疾病

Frontiers in Bioscience-Landmark

IF3.1

2026-04-010

PRE

Intestinal dysbiosis can progress ineffective bone mineral density (BMD) improvement with vitamin D in post-partum women

肠道菌群失调可能导致产后女性使用维生素D后骨矿物质密度（BMD）改善效果不佳。

Osteoporosis International

IF5.4

2025-12-180

PRE

Eradication of Pseudomonas aeruginosa using fixed-dose combination of probiotics and bacteriophages: development of an inhalable powder

使用益生菌和细菌噬菌体固定剂量组合清除铜绿假单胞菌：吸入粉剂的研发

International Journal of Pharmaceutics

IF5.2

2025-11-190

OAAI

Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines

纳米技术用于提高医用大麻和药物制剂的有效递送

Pharmaceuticals 2025, Vol. 18, Page 1385

IF4.8

2025-09-210

OAAI

A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal women

一项随机、双盲、安慰剂对照的临床研究，旨在评估合生元医疗食品SBD111在绝经女性骨丢失的临床膳食管理中的疗效。

Osteoporosis International

IF5.4

2025-08-150

OAAI

Pharmacokinetics and Bioavailability of Cannabinoids Administered via a Novel Orobuccal Nanoparticle Formulation (NanoCelle™) in Patients with Advanced Cancer

CANNABIS AND CANNABINOID RESEARCH

IF2.7

2025-03-010

PRE

Medicinal Cannabis and the Intestinal Microbiome

PHARMACEUTICALS

IF4.8

2024-12-171

OAAI

Respiratory Delivery of Lacticaseibacillus rhamnosus GG by Vibrating-Mesh and Jet Nebulisation

PHARMACEUTICS

IF5.5

2024-10-140

OAAI

Probiotics and magnesium orotate for the treatment of major depressive disorder: a randomised double blind controlled trial

SCIENTIFIC REPORTS

IF3.9

2024-09-061

OAAI

Probiotics and Commensal Bacteria Metabolites Trigger Epigenetic Changes in the Gut and Influence Beneficial Mood Dispositions

MICROORGANISMS

IF4.2

2023-05-186

OAAI

An exploratory study of the gut microbiota in major depression with anxious distress

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2023-01-0112

PRE

A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain

Inflammopharmacology

IF5.3

2022-09-040

OAAI

Can krill oil from small crustaceans be a panacea that alleviates symptoms of knee osteoarthritis?

AMERICAN JOURNAL OF CLINICAL NUTRITION

IF6.9

2022-09-010

OAAI

Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions

Inflammopharmacology

IF5.3

2022-07-070

OAAI

Re: Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial by Crippa et al.

CANNABIS AND CANNABINOID RESEARCH

IF2.7

2022-04-012

Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19 Comment on: Low-Grade Endotoxemia and Thrombosis in COVID-19

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY

IF3

2022-01-012

OAAI

Enhancing Endocannabinoid Control of Stress with Cannabidiol

JOURNAL OF CLINICAL MEDICINE

IF2.9

2021-12-1411

OAAI

The intestinal microbiota and improving the efficacy of COVID-19 vaccinations

JOURNAL OF FUNCTIONAL FOODS

IF4

2021-12-0125

OAAI

Intestinal dysbiosis in celiac disease: Decreased butyrate production may facilitate the onset of the disease

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2021-10-045

Luis Vitetta

个人简介

教育背景

工作经历

荣誉奖项

研究方向